Valley Cottage, NY -- (SBWIRE) -- 05/16/2019 -- Bioactive Bone Grafts is specialized reconstruction Martials which are prominently used in various bone reconstruction surgeries. Bone grafts usually comprise products like oesteocounductiove matrix that work as a framework for the growth of new bone fibers, osteoinductive proteins that support mitogenesis of identical bone cells and osteogenic cells which are capable of creating new bone in the appropriate environment. Primary objective behind the utilization of bone graft is to achieve healing from fractures and bone injuries. Bioactive bone grafts are designed to facilitate bone growth with optimized porosity that promotes rapid vascularization, playing an important role in the bone regrowth process by providing nutrients , oxygen, lymph And essential growth elements for bone growth. The bioactive bone grafts are formulated to provide ease in storage and handling. The property of bioactive bone grafts allows the products to be shaped into multiple forms to adopt to various surgical and operative needs. Furthermore, the prefilled syringes of bioactive bone grafts allows rapid and efficient application.

Bioactive Bone Grafts Market: Drivers and Restraints

Bioactive Bone Grafts are among the most preferred choice of bone graft in various bone reconstruction surgeries such as maxillofacial surgical procedures, due to their advantage over other allograft techniques. Increasing number of musculoskeletal disorder and orthopedic procedures which intends the utilization of bioactive bone grafts is anticipated to drive the growth of the bioactive bone grafts market. For example, as per the American academy of orthopedic surgeons (AAOS), nearly 2.8 million musculoskeletal surgical procedures are performed annually in the United States alone. In addition to this approximately 2.1 million orthopedic surgeries are performed every year in the United States involving the use of bone grafts and bioactive bone grafts. Thereby growing adoption of bioactive bone grafts combined with increasing incidence of orthopedic disorders demanding bioactive material is anticipated to boost the growth of bioactive bone grafts market. Furthermore, major key players introducing new products in the bioactive bone grafts segment that will lure additional number end users and thus drives the growth for bioactive bone grafts market. For example, Baxter in September 2018 announced the USFDA clearance of its ALTAPORE Bioactive Bone Grafts specially optimized to enhance bone growth.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7680

Bioactive Bone Grafts Market: Segmentation

Based on product type, the Bioactive Bone Grafts market is segmented into:

Prefilled

Putty based

others

Based on Application type, the Bioactive Bone Grafts market is segmented into:

Cranio-maxilofacial

Dental

Foot and Ankle

Joint Reconstruction

Others

Based on End User, the Bioactive Bone Grafts market is segmented into:

Hospitals

Clinics

Trauma Center

Emergency Department

Bioactive Bone Grafts Market: Overview

The Bioactive Bone Grafts market is observing a prominent growth globally owing to growing demand for advanced bone growth solutions combined with continuous research and product innovation in orthopedic care. The market for bioactive bone grafts is highly fragmented with presence of major manufacturers like Baxter and DePuy Synthes Companies in the bioactive bone grafts market. The advanced enhancement properties of bioactive bone grafts such as optimized porosity, increased cellular activity and greater volume of new formed bone is expected to offer new growth opportunities for bioactive bone grafts market. Surgical use of bioactive bone grafts in providing added osteoconductive scaffold for new bone growth coupled with enhanced bioactivity in rapid bone growth with calcium phosphate deposition. The primary key players in the bioactive bone growth market is focused on providing advanced bioactive bone growth products and improving clinical outcome. The growing number of geriatric population with arthritis condition and increasing number of accident are anticipated to act as primary driving factor for Bioactive Bone Grafts market.

Bioactive Bone Grafts Market: Region-Wise Overview

The global Bioactive Bone Grafts market is segmented into the following regions - North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific Excluding China & Japan, China, Japan and the Middle East & Africa. North America is the dominant regional market for Bioactive Bone Grafts due to growing number of geriatric population in the region. In North America, the U.S. is the dominating market due to segregation of Bioactive Bone Grafts manufacturers in the region combined with increasing investment in advanced medical technologies. Europe is anticipated to be second dominating regional market for Bioactive Bone Grafts due to wide availability of bioactive bone grafts and increasing technological advancement in orthopedic technologies in the region. APAC is a fast-growing regional market for Bioactive Bone Grafts due to increasing demand for standard orthopedic care and raising number of orthopedic injuries coupled with rising number of geriatrics in the countries like India and china. Growth in the Latin America and the Middle East and Africa is growing gradually due to progressively increasing healthcare spending.

Request to View TOC @ https://www.futuremarketinsights.com/toc/rep-gb-7680

Bioactive Bone Grafts Market: Key Participants

Examples of some of the key participants in the Bioactive Bone Grafts market are Baxter International, Inc., DePuy Synthes Companies, Medtronic plc., NuVasive, Inc., Orthofix Holdings, Inc., Stryker Corporation, Wright Medical Technology, Inc., Zimmer Biomet Holdings, Inc., and Bioventus. Among others.